Irina works closely with the Private Equity Team, global industry analysts, and other research resources across the firm to identify, research, and negotiate investments in private biotechnology companies.
Prior to joining Wellington in 2019, Irina was an equity research analyst at Cowen and Co., covering small- and mid-cap biotechnology companies. Before that, she worked on the wholesale lending risk management team for JPMorgan.
Irina holds a PhD in microbiology from the Icahn School of Medicine at Mount Sinai University. She also holds a BS in biochemistry and cell biology from Jacobs University (Germany) and an MS in biomolecular sciences from Utrecht University (Netherlands).
